Evidence map›Paper›PMID 39424842›Full record

ArticleScientific data2024

A multicenter bladder cancer MRI dataset and baseline evaluation of federated learning in clinical application.

Kangyang Cao, Yujian Zou, Chang Zhang, Weijing Zhang, Jie Zhang, Guojie Wang, Chu Zhang, Jiegeng Lyu, Yue Sun, Hongyuan Zhang and 5 more

Abstract readDatasetMulticenter Study
In one paragraph

Article in Scientific data, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Kangyang Cao *Medical AI Lab, School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenzhen, 518060, China.
Yujian Zou *Department of Radiology, The Tenth Affiliated Hospital of Southern Medical University (Dongguan people's hospital), Dongguan, China.
Chang Zhang *Medical AI Lab, School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenzhen, 518060, China.
Weijing Zhang *Imaging Department, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Jie Zhang *Department of Radiology, Affiliated Zhuhai Hospital, Jinan University, Zhuhai, Guangdong, China.
Guojie Wang *Department of Radiology, Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong, China.
Chu ZhangMedical AI Lab, School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenzhen, 518060, China.
Jiegeng LyuMedical AI Lab, School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenzhen, 518060, China.
Yue SunFaculty of Applied Sciences, Macao Polytechnic University, Macao, 999078, China.
Hongyuan ZhangMedical AI Lab, School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenzhen, 518060, China.ORCID 0000-0002-0657-1862
Bin HuangMedical AI Lab, School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenzhen, 518060, China.
Lei DengDepartment of Radiology, The Tenth Affiliated Hospital of Southern Medical University (Dongguan people's hospital), Dongguan, China.
Shuiqing YangDepartment of Radiology, The Tenth Affiliated Hospital of Southern Medical University (Dongguan people's hospital), Dongguan, China.
Jianpeng LiDepartment of Radiology, The Tenth Affiliated Hospital of Southern Medical University (Dongguan people's hospital), Dongguan, China. lijianpeng_217@163.com.
Bingsheng HuangMedical AI Lab, School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenzhen, 518060, China. huangb@szu.edu.cn.ORCID 0000-0002-1183-7506

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bladder cancer (BCa), as the most common malignant tumor of the urinary system, has received significant attention in research on the clinical application of artificial intelligence algorithms. Nevertheless, it has been observed that certain investigations use data from various medical facilities to train models for BCa, which may pose a privacy risk. Given this concern, protecting patient privacy during machine learning algorithm training is a crucial aspect that requires substantial attention. One emerging machine learning paradigm that addresses this concern is federated learning (FL). FL enables multiple entities to collaboratively build machine learning models while preserving data privacy and security. In this study, we present a multicenter BCa magnetic resonance imaging (MRI) dataset. The dataset comprises 275 three-dimensional bladder T2-weighted MRI scans collected from four medical centers, and each scan includes diagnostic pathological labels for muscle invasion and pixel-level annotations of tumor contours. Four FL methods are used to assess the baseline of the dataset for both the task of diagnosing muscle-invasive bladder cancer and automatic bladder tumor lesion segmentation.

Indexed as

Machine LearningMagnetic Resonance ImagingUrinary Bladder NeoplasmsAlgorithmsHumans

Identifiers

PMID39424842
PMCPMC11489429

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.